Australian Clinical Labs Limited (ASX: ACL)
Sector: Health Care
Market cap: A$616M (as of 2 Nov 2026)
Provision of pathology services
Data as of 2 Nov 2026.
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 30 Oct 2026 | Allan Gray Australia Pty Ltd (Allan Gray Australia) and its related bodies corporate (together the Group) | Decrease | 17.8% → 16.71% | Filing ↗ |
| 29 Oct 2026 | Comet Asia Holdings II Pte. Ltd., Comet Asia Holdings I Pte. Ltd., KKR Asia III Fund Investments Pte. Ltd. and KKR Asian Fund III L.P. (KKR Entities) | Decrease | 8.21% → 7.2% | Filing ↗ |
| 21 Aug 2026 | Mitsubishi UFJ Financial Group, Inc. | Increase | 7.51% → 8.71% | Filing ↗ |
| 19 Aug 2026 | Investors Mutual Limited | Exit | — | Filing ↗ |
| 17 July 2026 | Mitsubishi UFJ Financial Group, Inc. | Decrease | 8.66% → 7.51% | Filing ↗ |
Director trades — on-market
Ask about ACL in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has ACL raised money in the last year, and at what discount?
- What was ACL's latest cash position and runway?
Loading ACL…